ClinicalTrials.gg
CompletedNCT05690269Updated May 31, 2025

Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry

An observational study in Hypoxemia, Hyperoxia and Pigment Skin, sponsored by University of Cincinnati. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by University of Cincinnati · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
232
Ages
18 Years and older
Sex
All
01

Study summary

Finger pulse oximetry SpO2 is widely used to estimate arterial oxygen saturation SaO2. Current Spo2 targets do not take into consideration the many variables that affect that correlation in particular skin pigmentation.

This study aims to evaluate different FDA approved pulse oximeters (Nonin co-pilot, massimo Radical 7, Philips-standard of care monitor, innovo premium iP900BP, nellcor PM1000N, Nano100) with SaO2 reference values obtained by an arterial blood gas in subjects with different skin pigments measured by a skin color scale as well as self-identification of race.

Read the detailed description

The oximeters that will be evaluated are nonin co-pilot, massimo Radical 7, Philips (standard care), Innovo Premium iP900BP, nellcor PM1000N and USA medical supply Nano100. The sensors used will be reusable digital sensors for all oximeters. Oximeters will have been placed on patients' fingers (3 fingers on each hand) during an initial phase of clinical stability. Due to the impact of the fingers used for SpO2 measurement and bias that might be caused by right hand versus left hand, oximeters will be randomized to different fingers and hands for each patient. Measurements will be made when the SpO2 with the usual oximeter is \<97% as recommended and in the absence of changes of the respiratory parameters in the last 10 minutes. A set of measures that will include all the oximeters tested will be used. Once the oximeters are installed, at least 2 minutes will run out to let the oximeters reach steady state. Then when a standard of care blood gas is obtained, measurements will be taken simultaneously to the drawing of a standard care arterial blood gas by a clinician in the ICU. While the clinician takes the arterial blood gas, a picture will be simultaneously taken of the SpO2 readings shown by each oximeter, in addition to taking vital signs, O2 flow or FiO2.

02

Conditions studied

  • Hypoxemia
  • Hyperoxia
  • Pigment Skin

Keywords

  • SpO2, SaO2,Hypoxemia
03

In context

Hypoxia

1,076 studies on the registry are indexed under Hypoxia; 213 are open to participants now.

This study's enrollment of 232 is above the median of 79 across 277 observational studies indexed under Hypoxia.

Browse Hypoxia studies →

Lead sponsor

University of Cincinnati is the lead sponsor of 324 studies on the registry; 42 are open to participants now.

Of its 24 completed or terminated interventional studies of FDA-regulated products, 15 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

ICU patients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 18 years old
  • Patients admitted to the Intensive Care Unit
  • Patient has arterial line

Exclusion criteria

Exclusion Criteria:

  • No signal with the oximeter
  • Missing digits preventing application of all probes simultaneously
  • No requirement for arterial blood gases
  • Pigmented nails, fake nails, or nail polish
  • Methemoglobinemia
  • Patient in isolation (multi-resistant bacteria, C-Difficile, COVID-19)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
232 participants (actual)
Patient registry
No

Interventions

  • DeviceSpO2 and SaO2 comparison

    Several pulse oximeter will be place on patients fingers a few minutes before arterial blood gases. SpO2 will be recorded during that time and up to 10 minutes.

06

What researchers measure

Primary outcomes

  1. Difference between SpO2 and the SaO2 value in all studied oximeters

    Difference between oximeter SpO2 and the corresponding SaO2 value

    Time frame: At the time of arterial blood samples collection. Approximately 15 minutes.

Secondary outcomes

  1. Evaluation of oximeter accuracy in subpopulations of subjects with hypothermia

    Evaluation of oximeter accuracy in subpopulations of subjects with hypothermia (body temperature \< 34 degrees C) and subjects requiring vasoactive infusions.

    Time frame: At the time of arterial blood samples collection. Approximately 15 minutes.

07

Study locations

1 site
  • University of Cincinnati
    Cincinnati, Ohio 45267, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05690269
Collaborators
United States Air Force
Responsible party
Dina Gomaa (Assistant Professor, University of Cincinnati) — Principal investigator
First posted
Jan 19, 2023
Start date
Feb 27, 2023
Primary completion
Mar 31, 2025
Completion
Mar 31, 2025
Last update
May 31, 2025

Study contacts

Dina Gomaa, MSc
principal investigator · University of Cincinnati

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion